NCT00160134View on ClinicalTrials.gov

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2005

Conditions

Congestive Heart Failure

Interventions

DRUG

SLV320

Trial Locations (1)

Unknown

Site 1, Bad Nauheim

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00160134 - Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure | Biotech Hunter | Biotech Hunter